Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Exponent (EXPO) over the last 13 years, with Oct 2025 value amounting to $12.2 million.

  • Exponent's Change in Accured Expenses rose 315.12% to $12.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.6 million, marking a year-over-year increase of 160.63%. This contributed to the annual value of $495,000 for FY2025, which is 109.79% up from last year.
  • Latest data reveals that Exponent reported Change in Accured Expenses of $12.2 million as of Q4 2025, which was up 222.52% from $3.8 million recorded in Q3 2025.
  • Over the past 5 years, Exponent's Change in Accured Expenses peaked at $29.6 million during Q3 2021, and registered a low of -$29.6 million during Q1 2024.
  • For the 3-year period, Exponent's Change in Accured Expenses averaged around -$1.5 million, with its median value being $3.8 million (2025).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 896.71% in 2021, then tumbled by 65.69% in 2025.
  • Over the past 5 years, Exponent's Change in Accured Expenses (Quarterly) stood at $14.6 million in 2021, then rose by 21.67% to $17.7 million in 2022, then slumped by 54.43% to $8.1 million in 2023, then fell by 3.66% to $3.0 million in 2024, then skyrocketed by 315.12% to $12.2 million in 2025.
  • Its Change in Accured Expenses stands at $12.2 million for Q4 2025, versus $3.8 million for Q3 2025 and -$27.6 million for Q2 2025.